114 related articles for article (PubMed ID: 6127884)
21. Pharmacokinetics of prenalterol in healthy subjects and patients with congestive heart failure.
Rönn O
Acta Med Scand Suppl; 1982; 659():89-98. PubMed ID: 6127901
[TBL] [Abstract][Full Text] [Related]
22. [Echocardiographic measurements of hemodynamic effects and pharmacokinetics of prenalterol (author's transl)].
Oltmanns D; Wester HA; Stein R
Z Kardiol; 1981 May; 70(5):394-8. PubMed ID: 6115520
[TBL] [Abstract][Full Text] [Related]
23. The metabolic disposition of the selective beta 1-adrenoceptor agonist prenalterol in mice, rats, dogs, and humans.
Hoffmann KJ; Arfwidsson A; Borg KO
Drug Metab Dispos; 1982; 10(2):173-9. PubMed ID: 6124405
[TBL] [Abstract][Full Text] [Related]
24. Prenalterol is an agonist at beta 2- as well as at beta 1-adrenoceptors.
Apperley GH; Drew GM; Sullivan AT
Eur J Pharmacol; 1982 Jul; 81(4):659-63. PubMed ID: 6126381
[TBL] [Abstract][Full Text] [Related]
25. Metabolic and hormonal effects of preferential beta 1 and beta 2-adrenoceptor stimulation in man.
Tantucci C; Santeusanio F; Beschi M; Castellano M; Sorbini C; Grassi V
J Endocrinol Invest; 1988 Apr; 11(4):279-87. PubMed ID: 2842389
[TBL] [Abstract][Full Text] [Related]
26. The lack of a pronounced preference of prenalterol for the beta-l-adrenoceptor subtype.
Rohm N; Wagner J; Schümann HJ
Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(1):85-8. PubMed ID: 6113550
[TBL] [Abstract][Full Text] [Related]
27. The haemodynamic effects of intravenous prenalterol and ouabain in conscious dogs.
Ek L; Björkman JA; Carlsson E; Johansson B
Acta Med Scand Suppl; 1982; 659():39-52. PubMed ID: 6127899
[TBL] [Abstract][Full Text] [Related]
28. Cardiostimulatory effects of prenalterol, a beta-1 adrenoceptor partial agonist, in vivo and in vitro. Correlation between physiological effects and adenylate cyclase activity.
Hedberg A; Carlsson E; Fellenius E; Lundgren B
Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):185-91. PubMed ID: 6121296
[TBL] [Abstract][Full Text] [Related]
29. Effect of prenalterol, a beta-1-adrenoceptor agonist, on renin secretion rate in the anaesthetized dog.
Kopp U; Aurell M; Svensson L; Ablad B
Acta Pharmacol Toxicol (Copenh); 1981 Sep; 49(3):230-5. PubMed ID: 6121458
[TBL] [Abstract][Full Text] [Related]
30. Cardio-selective beta adrenergic stimulation with prenalterol in the conscious dog.
Manders WT; Vatner SF; Braunwald E
J Pharmacol Exp Ther; 1980 Oct; 215(1):266-70. PubMed ID: 6109017
[TBL] [Abstract][Full Text] [Related]
31. Ultrastructural changes in rat parotid acinar cells after selective beta 1-adrenoceptor agonist treatment.
Bloom GD; Carlsöö B; Danielsson A; Domeij S; Henriksson R
Med Biol; 1983; 61(6):305-12. PubMed ID: 6144823
[TBL] [Abstract][Full Text] [Related]
32. beta 1-Adrenoceptors mediating relaxation of the guinea-pig trachea: experiments with prenalterol, a beta 1-selective adrenoceptor agonist.
Johansson U; Waldeck B
J Pharm Pharmacol; 1981 Jun; 33(6):353-6. PubMed ID: 6115005
[TBL] [Abstract][Full Text] [Related]
33. Influence of heart rate on the effects of prenalterol on regional myocardial blood flow and function during coronary stenosis in dogs.
Berdeaux A; Bonhenry C; Duhazé P; Giudicelli JF; Thuillez C
Br J Pharmacol; 1984 Sep; 83(1):203-10. PubMed ID: 6148979
[TBL] [Abstract][Full Text] [Related]
34. Basic pharmacological properties of prenalterol.
Mattsson H; Hedberg A; Carlsson E
Acta Med Scand Suppl; 1982; 659():9-37. PubMed ID: 6127902
[No Abstract] [Full Text] [Related]
35. A comparison of the hemodynamic effects of prenalterol and isoprenaline in patients with complete heart block.
Svendsen TL; Pelle H; Lønholt C; Bonde J; Kampmann JP; Lindeneg O
J Cardiovasc Pharmacol; 1984; 6(4):693-6. PubMed ID: 6206327
[TBL] [Abstract][Full Text] [Related]
36. beta 1-and beta 2-adrenoceptor stimulatory effects of prenalterol.
Mattsson H; Andersson T; Carlsson E; Hedberg A; Lundgren B; Olsson T
Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(4):302-8. PubMed ID: 6132344
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic studies in man of the selective beta 1-adrenoceptor agonist, prenalterol.
Graffner C; Hoffmann KJ; Johnsson G; Lundborg P; Rönn O
Eur J Clin Pharmacol; 1981; 20(2):91-7. PubMed ID: 6114866
[TBL] [Abstract][Full Text] [Related]
38. Effects of in vivo treatment with isoprenaline or prenalterol on beta-adrenoceptor mechanisms in the heart and soleus muscle of the cat.
Hedberg A; Mattsson H; Nerme V; Carlsson E
Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar; 325(3):251-8. PubMed ID: 6145101
[TBL] [Abstract][Full Text] [Related]
39. Inotropic effect of prenalterol in amitriptyline poisoning.
Heath A; Mårin P; Sjöstrand I
Intensive Care Med; 1984; 10(4):209-11. PubMed ID: 6147367
[TBL] [Abstract][Full Text] [Related]
40. Haemodynamic effects, plasma concentrations and tolerance of orally administered prenalterol in man.
Weiss A; Pfister B; Imhof P; Degen PH; Burckhardt D; Dubach UC
Eur J Clin Pharmacol; 1980 Nov; 18(5):383-90. PubMed ID: 6108221
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
